16188621

Source:http://linkedlifedata.com/resource/pubmed/id/16188621

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019829, umls-concept:C0441994, umls-concept:C0443252, umls-concept:C0600688, umls-concept:C0683525, umls-concept:C1306673, umls-concept:C1521828, umls-concept:C1880198
pubmed:dateCreated	2005-9-28
pubmed:abstractText	The definition of early stages in HL varied among cooperative groups and clinical trials. Most of them considered early stages; stage I, II, and IIIA without bulky disease. Bulky disease has been defined at the Costwolds Meeting as those tumors with more than 10 cm or a mediastinal involvement of more than one-third of the chest wall diameter. Other factors that have been considered unfavorable within the early stages are old age, high ESR, mixed cellularity or lymphocyte depleted histology, B symptoms or multiple sites of disease.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9708388
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:issn	1024-5332
pubmed:author	pubmed-author:PavlovskySantiagoS
pubmed:issnType	Print
pubmed:volume	10 Suppl 1
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	3-5
pubmed:meshHeading	pubmed-meshheading:16188621-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16188621-Combined Modality Therapy, pubmed-meshheading:16188621-Hodgkin Disease, pubmed-meshheading:16188621-Humans, pubmed-meshheading:16188621-Neoplasms, Second Primary
pubmed:year	2005
pubmed:articleTitle	Treatment options in early stages of Hodgkin's Lymphoma, high cure rate with lower short and long-term toxicity.
pubmed:affiliation	FUNDALEU, Centro de Internación e Investigación Clínica Angélica Ocampo, Buenos Aires, Argentina.
pubmed:publicationType	Journal Article, Review